Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

FOXK2 Transcription Factor and Its Emerging Roles in Cancer.

Nestal de Moraes G, Carneiro LDT, Maia RC, Lam EW, Sharrocks AD.

Cancers (Basel). 2019 Mar 20;11(3). pii: E393. doi: 10.3390/cancers11030393. Review.

2.

The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.

Yao S, Fan LY, Lam EW.

Semin Cancer Biol. 2018 Jun;50:77-89. doi: 10.1016/j.semcancer.2017.11.018. Epub 2017 Nov 24. Review.

3.

ER stress and cancer: The FOXO forkhead transcription factor link.

Alasiri G, Fan LY, Zona S, Goldsbrough IG, Ke HL, Auner HW, Lam EW.

Mol Cell Endocrinol. 2018 Feb 15;462(Pt B):67-81. doi: 10.1016/j.mce.2017.05.027. Epub 2017 May 29. Review.

4.

Dataset of the human homologues and orthologues of lipid-metabolic genes identified as DAF-16 targets their roles in lipid and energy metabolism.

Fan LY, Saavedra-GarcĂ­a P, Lam EW.

Data Brief. 2017 Mar 8;11:606-610. doi: 10.1016/j.dib.2017.02.055. eCollection 2017 Apr.

5.

The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.

Nestal de Moraes G, Castro CP, Salustiano EJ, Dumas ML, Costas F, Lam EW, Costa PR, Maia RC.

Int J Oncol. 2014 Nov;45(5):1949-58. doi: 10.3892/ijo.2014.2615. Epub 2014 Aug 21.

PMID:
25174716

Supplemental Content

Loading ...
Support Center